What is Autonomize?
Headquartered in Austin, Texas, Autonomize is a pioneering artificial intelligence (AI) technology company operating at the intersection of healthcare and life sciences. The company leverages advanced AI solutions to address complex challenges within these critical industries, aiming to drive innovation and improve outcomes. Its focus on AI in healthcare and life sciences positions it within a rapidly growing market segment characterized by significant technological advancement and increasing demand for data-driven insights and solutions.
How much funding has Autonomize raised?
Autonomize has raised a total of $32M across 2 funding rounds:
Angel/Seed
$4M
Series A
$28M
Angel/Seed (2023): $4M with participation from The Next Practices Group
Series A (2025): $28M led by ATX Venture Partners, Valtruis, Cigna, Tau Ventures, and Asset Management
Key Investors in Autonomize
ATX Venture Partners
ATX Venture Partners is an early-stage venture capital firm based in Austin, Texas, focusing on investments in disruptive B2B software, APIs, marketplaces, and frontier technology across North America. Their value-add approach emphasizes collaboration with portfolio companies to enhance their business models and market positioning.
Valtruis
Valtruis provides a unique platform that invests in and partners with disruptive leaders to transform healthcare through value-based care, focusing on revolutionizing how care is accessed, delivered, experienced, and paid for.
Cigna
The Cigna Group is a global health company committed to improving health and vitality through innovative solutions for better health, operating through Cigna Healthcare and Evernorth Health Services.
What's next for Autonomize?
The recent major strategic investment signifies a pivotal moment for Autonomize, likely enabling the company to accelerate its product development, expand its market reach, and further solidify its position in the competitive healthcare AI landscape. This infusion of capital is expected to fuel growth initiatives, potentially including team expansion, strategic partnerships, and the enhancement of its AI platforms to deliver greater value to clients in the healthcare and life sciences sectors. The company's trajectory suggests a focus on scaling its operations and capitalizing on the increasing adoption of AI within its target industries.
See full Autonomize company page
